Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02536183
Recruitment Status : Recruiting
First Posted : August 31, 2015
Last Update Posted : November 19, 2018
Sponsor:
Information provided by (Responsible Party):
AeRang Kim, Children's Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2020
  Estimated Study Completion Date : October 2020